September 13TH,2022 — This new report from Stratview Research analyses the Diabetes Injection Pens Market over the trend period from 2014 to 2019 and forecast period from 2021 to 2026. The insights of the report shall enable informed decision making and strategy formulation for the near future to capitalize on the opportunities.

Diabetes Injection Pens Market Overview:

The sudden outbreak of the COVID-19 has led to unforeseen fluctuations across many industries and the Diabetes Injection Pens Market is no different. Derived from the previous market scenario, the Diabetes Injection Pens Market is likely to witness an impressive CAGR of 4.9% during the forecast period but with the global crisis in action, the growth curve has deviated from its expected path and exhibits an uncertain trajectory at present. 

Get access to a deeper coverage of the impact of COVID-19 on this Market here:

The Diabetes Injection Pens Market is segmented by–

  •  (Reusable Injection Pens, Disposable Injection Pens)
  •  (Retail Pharmacies, Online Medical Stores, Diabetes Clinics, Others)

Key Players:

  • Novo Nordisk (Denmark)
  • Eli Lilly (US)
  • Sanofi (France)
  • BD (US)
  • Ypsomed Holding (Switzerland)
  • Dongbao (China)
  • Owen Mumford (UK)
  • Ganlee (China)
  • Delfu (China)
  • Biocon Ltd (India)

Regional analysis:

By region, the North America Diabetes Injection Pens market accounted the highest share in 2020 and is expected to grow at a robust CAGR during the review period. The Diabetes Injection Pens market growth is mainly attributed favorable reimbursement scenario, surging prevalence of diabetes, and the rising number of awareness programs which bolsters the regional market growth.

About Stratview Research

Stratview Research is a global market intelligence firm providing wide range of services including syndicated market reports, custom research and sourcing intelligence across industries, such as Advanced Materials, Aerospace & Defense, Automotive & Mass Transportation, Consumer Goods, Construction & Equipment, Electronics and Semiconductors, Energy & Utility, Healthcare & Life Sciences, and Oil & Gas.

For enquiries,
Stratview Research
Direct: +1-313-307-4176